Recent solubility and dissolution enhancement techniques for repaglinide a BCS class II drug: a review

Repaglinide is an oral blood-glucose-lowering drug used to manage type-2 diabetes mellitus by lowering post-prandial glucose by stimulating insulin secretion from pancreatic beta cells. According to the biopharmaceutical classification system, repaglinide falls under the class II category. For such...

Full description

Saved in:
Bibliographic Details
Main Authors: Saba Albetawi (Author), Amer Abdalhafez (Author), Ala Abu-Zaid (Author), Aseel Matrouk (Author), Noor Alhourani (Author)
Format: Book
Published: Pensoft Publishers, 2021-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available